News

Victorian Government Technology Minister Gordon Rich-Phillips said the Government’s Enabling Technologies Skills Strategy – Biotechnology: 2012-15 will further develop the commercial, business and technical skills of Victoria’s biotechnology

The production facility will be co-located with the pharmaceutical production site based in Tuas, Singapore. Novartis CEO Joseph Jimenez said, "We have chosen Singapore as strategic supply point

The data reveales the relationship (p=0.003) between EVP-6124 plasma concentrations and the probability of cognitive improvement measured by the Alzheimer’s Disease Assessment Scale-Cognitive subscale-13. EnVivo Pharmaceuticals president and

Nefecon, an enteric formulation of a locally-acting and potent corticosteroid, inhibits the gastrointestinal immune system and down regulates the IgA nephropathy disease process. Commercial terms of the agreement

Adcetris is indicated for use in adult patients with relapsed or refractory CD30 positive Hodgkin lymphoma (HL) or relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). The

The company anticipates launching the generic drug in or prior to the first quarter of 2013. Sihuan chairman and CEO Dr. Che Fengsheng said based on the hospital

Exceeding 35,000ft², the new facility features an expanded class 10,000 clean room which is designed for manufacturing Finesse single use sensors. The building also includes an expanded floor

Under the contract, Cytovance will develop FB301 at its process development and analytical laboratories and manufacture at its 44,000ft² production facility. In addition, Cytovance will spearhead the cell

The ongoing double-blind 48-week trial is evaluating TAF 10mg/elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg with Stribild in treatment-naïve adults. A comparable virologic response was observed at 24 weeks of therapy